Document: Report: European medicines regulatory network’s response to nitrosamine impurities in human medicines-2025/7/29

Document: Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases-2025/9/15

关于公开征求《化学仿制药参比制剂目录（第九十九批）》（征求意见稿）意见的通知-2025/10/17

Document: Regulatory Procedure Management in IRIS roadmap-2025/11/21

Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (14 November - 11 December 2025)-2025/12/16

国家药监局药审中心关于发布《细胞治疗药品药学变更研究与评价技术指导原则（试行）》的通告（2026年第13号）-2026/1/30

Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/3/9

国家药监局药审中心关于发布《药物上市申请临床评价技术指导原则》的通告（2026年第26号）-2026/4/8

国家药监局 海关总署关于麻醉药品和精神药品进出口管理有关事宜的公告（2022年第115号 ）-2022/12/22

Scientific guideline: Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol-2023/7/4